VYNE
Vyne Therapeutics Inc
NASDAQ: VYNE · HEALTHCARE · BIOTECHNOLOGY
$0.67
+0.53% today
Updated 2026-05-06
Market cap
$21.39M
P/E ratio
—
P/S ratio
37.52x
EPS (TTM)
$-0.63
Dividend yield
—
52W range
$0 – $2
Volume
0.2M
Vyne Therapeutics Inc (VYNE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $674000.00 | $4.58M | $10.64M | $1.75M | $20.99M | $931000.00 | $477000.00 | $424000.00 | $501000.00 | $570000.00 |
| Revenue growth (YoY) | — | — | +579.8% | +132.2% | -83.6% | +1099.6% | -95.6% | -48.8% | -11.1% | +18.2% | +13.8% |
| Cost of revenue | — | — | — | — | $350000.00 | $1.39M | $3.35M | — | — | $4000.00 | $23000.00 |
| Gross profit | — | $674000.00 | $4.58M | $10.64M | $93000.00 | $19.60M | $931000.00 | $477000.00 | $424000.00 | $501000.00 | $547000.00 |
| Gross margin | — | 100.0% | 100.0% | 100.0% | 5.3% | 93.4% | 100.0% | 100.0% | 100.0% | 100.0% | 96.0% |
| R&D | $2.92M | $11.26M | $29.01M | $52.99M | $53.76M | $43.53M | $19.54M | $18.39M | $16.31M | $30.95M | $19.24M |
| SG&A | $1.69M | $3.75M | $5.17M | $12.19M | $22.48M | $89.54M | $54.48M | $16.39M | $13.38M | $13.19M | $11.08M |
| Operating income | $-4.61M | $-14.33M | $-29.59M | $-54.53M | $-76.24M | $252.55M | $-38.91M | $-34.30M | $-29.26M | $-43.64M | $-29.75M |
| Operating margin | — | -2126.4% | -645.9% | -512.5% | -4356.7% | 1203.0% | -4179.5% | -7189.7% | -6900.5% | -8710.0% | -5219.1% |
| EBITDA | $-4.61M | $-14.33M | $-29.59M | $-54.51M | $-75.54M | $-251.09M | $-38.80M | $-34.22M | $-29.26M | $-43.63M | $-26.73M |
| EBITDA margin | — | -2125.8% | -645.7% | -512.3% | -4316.7% | -1196.1% | -4167.8% | -7174.6% | -6900.5% | -8709.2% | -4689.8% |
| EBIT | $-4.61M | $-14.33M | $-29.59M | $-54.53M | $-76.24M | $-251.44M | $-38.91M | $-34.30M | $-29.00M | $-43.64M | — |
| Interest expense | $0.00 | $0.00 | $517000.00 | $3.09M | $2.54M | $4.39M | $5.61M | $10.81M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-4.61M | $-14.07M | $-29.08M | $-51.45M | $-70.46M | $-255.57M | $-73.33M | $-23.21M | $-28.45M | $-39.83M | $-26.48M |
| Net income growth (YoY) | — | -205.3% | -106.7% | -76.9% | -37.0% | -262.7% | +71.3% | +68.3% | -22.6% | -40.0% | +33.5% |
| Profit margin | — | -2087.2% | -634.6% | -483.5% | -4026.5% | -1217.4% | -7876.4% | -4865.8% | -6710.4% | -7950.9% | -4646.1% |